U.S. drug manufacturers import at least 80% of their active pharmaceutical ingredients with an every increasing share coming from China and India. We’ll discuss some of the new questions being raised about safety standards of these imports.


  • Marc Kaufman Reporter on the national desk of "The Washington Post"
  • Dr. Gilbert Ross Medical/Executive Director American Council on Science and Health
  • Caroline Loew SVP, Scientific and Regulatory Affairs, PhRMA
  • Dr. Sidney Wolfe Director of the Health Research Group at Public Citizen; editor of WorstPills.org
  • Sen. Charles Grassley (R-Iowa), ranking member of the Senate Finance Committee


comments powered by Disqus
Most Recent Shows